"Avoidable Deaths" - Union for International Cancer Control

"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group

"Bald for a Cause" initiative - UWC Dilijan College

Catherine Alix-Panabières: Honored to moderate at ESMO European Lung Cancer Congress 2025

Steven Kridel: Applications are open for the Wake PREP2PhD program

SABCS24 Day 2 Highlights from Oncology Brothers

Oncology Brothers, Hematology-Oncology Fellow

Ziad Peerwani and Scott Kilpatrick emphasize the importance of accurate pathology diagnosis

Eleni (Lina) Tolma: The power of prevention and screening in saving lives

Amer Zeidan Invites to Join ASCO 2025 PER Symposium on Acute Myeloid Leukemia

Insight

Sep 29, 2023

Insight

Nirmala Bhoo Pathy: We are so proud to share our report on Women, Power and Cancer.

Sep 28, 2023

Insight

Ophira Ginsburg: Many thanks to the incredible team at The Lancet for making this possible.

Sep 28, 2023

Insight

Rachel Shelton: Our new piece is out in Frontiers on making the connection between health equity and sustainability in Implementation Science.

Sep 28, 2023

Insight

Maite Bourlon: Happy collaborator: Women, Power and Cancer at The Lancet Commission.

Sep 28, 2023

Insight

Neil Iyengar: We found Hb A1c and BMI were early risk factors for treatment discontinuation.

Sep 28, 2023

Insight

Diogo Martins Branco: Meta-analysis of Ki-67 prognostic value after neoadjuvant endocrine therapy.

Sep 28, 2023

Insight

Marion Campbell: If you wish to use a patient-reported outcome measure in your trial, it is important to choose your measure wisely to ensure that you won’t observe ‘floor’ or ‘ceiling’ effects in your data.

Sep 28, 2023

Insight

Ramy Sedhom: Lessons from ASCO Palliative Care Communities of Practice chat with Eduardo Bruera on “How to Build a Clinical Palliative Care Program”.

Sep 27, 2023

Insight

Aakash Desai: Out in Journal of Thoracic Oncology our editorial “Toxicity From Sotorasib after ICI: A Note of Caution and Reflections of Future Advancements in the Field”.

Sep 27, 2023

Insight

Yüksel ÜRÜN: Our paper titled “Adjuvant Therapy for Renal Cell Carcinoma: A Systematic Review of Current Landscape and Future Directions” is now online.